The identification of PD-L1-positive CTCs from liquid biopsy samples may be a promising means to evaluate PD-L1 expression patterns in UC, regardless of the heterogeneous expression in the primary tumor site and the metastatic lesions. The gene discussed is CD274; the disease is neoplasm.